Nanocarriers Strategies against Microorganisms and Their Associated Biofilm Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 11766
Special Issue Editor
Interests: biomaterial; nanocarriers; polymers; antibiotic resistance; the effects of natural or synthetic molecules on fungi and bacteria; Staphylococcus aureus; Candida albicans
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biofilms, which are formed by bacteria and fungi within a complex biological system, are a major challenge to treating chronic microorganism-associated infections globally. Common fungal and bacterial infections are caused by Candida albicans, and Staphylococcus aureus exerts a large burden on the healthcare system. In several niches in the host, C. albicans coexists with various bacterial species, especially S. aureus. The formation of multispecies biofilms leads to increasing the chances of drug failure. Thus, nanocarriers are the perfect candidates for answering this challenge because they show desirable stability, improve the aqueous solubility of lipophilic molecules, show excellent biodegradability, enhance bioavailability and bioefficiency, and decrease toxicity. Therefore, nano-drug delivery has been established and developed as an alternative technique to improve the effectiveness of antifungals and antibiotics against biofilms. The effective penetration capabilities of nanocarriers inside the biofilm can help to improve the drug potency for treating several diseases, including biofilm-associated bacterial and fungal infections.
Dr. Vinit Raj
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Candida albicans and Staphylococcus aureus
- nanocarriers
- biofilm
- antimicrobial resistance
- natural and synthetic molecules
- drug design
- QSAR
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.